Decline in breast cancer: Not just because of hormone therapy

Dec 08, 2009

Between 2002 and 2003, American women experienced a 7 percent decline in breast cancer incidence, which scientists attribute to the publicity surrounding results of the Women's Health Initiative (WHI).

However, researchers led by Brian Sprague, Ph.D. have conducted a reevaluation of the post-WHI landscape that suggests otherwise.

"We found that the change in hormone therapy use only accounted for a decline of about 3 percent, so there's another 4 percent that is being caused by something we do not yet know," said Sprague, a postdoctoral fellow at the University of Wisconsin.

Results of this study were presented at the American Association for Cancer Research Frontiers in Cancer Prevention Research Conference, held Dec. 6-9 in Houston.

In 1991, the National Institutes of Health established the WHI to address the most common causes of death, disability and deterred quality of life among 15,730 postmenopausal — cancer, cardiovascular disease and osteoporosis.

Results of the WHI demonstrated in 2002 that hormone therapy is linked with an increased risk of . Other studies have confirmed this relationship, and many women have stopped taking hormone therapy due to concerns about the potential risk of cancer. At the same time, the incidence of breast cancer has declined, which researchers attribute to the decrease in hormone therapy use.

After conducting a thorough literature review of the decline in hormone use and the decline in breast cancer incidence, Sprague and colleagues estimated that 42 percent of the decline in incidence of breast cancer was linked to the cessation of use.

Sprague said that additional studies are needed to determine the source of the remaining decline in breast cancer cases.

"This does not mean that women should start taking hormones again, but there appear to be additional factors that have contributed to the decline in breast cancer," he said.

Source: American Association for Cancer Research (news : web)

Explore further: Researchers develop web-based app to predict glioma mutations

add to favorites email to friend print save as pdf

Related Stories

Recommended for you

Biomarker in aggressive breast cancer identified

13 hours ago

Two Northwestern University scientists have identified a biomarker strongly associated with basal-like breast cancer, a highly aggressive carcinoma that is resistant to many types of chemotherapy. The biomarker, ...

MRI better detects recurrent breast cancer

14 hours ago

(HealthDay)—Single-screening breast magnetic resonance imaging (MRI) detects 18.1 additional cancers after negative findings with mammography and ultrasonography (US) per 1,000 women with a history of breast ...

Natural (born) killer cells battle pediatric leukemia

Aug 19, 2014

Researchers at Children's Hospital Los Angeles have shown that a select team of immune-system cells from patients with leukemia can be multiplied in the lab, creating an army of natural killer cells that ...

User comments : 0